VIVUS, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.6M
Doctors Paid
8,220
Transactions
24,079
2024 Total
$245,506
Payment Breakdown by Category
Research$9.5M (69.5%)
Royalty/License$3.0M (22.4%)
Consulting$487,593 (3.6%)
Food & Beverage$418,589 (3.1%)
Travel$43,998 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.5M | 1,239 | 69.5% |
| Royalty or License | $3.0M | 29 | 22.4% |
| Consulting Fee | $487,593 | 107 | 3.6% |
| Food and Beverage | $418,589 | 22,545 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,680 | 64 | 0.8% |
| Travel and Lodging | $43,998 | 71 | 0.3% |
| Charitable Contribution | $39,000 | 15 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $12,050 | 6 | 0.1% |
| Education | $24.78 | 3 | 0.0% |
Payments by Type
Research
$9.5M
1,239 transactions
General
$4.2M
22,840 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject | $4.4M | 0 | 292 |
| A Phase IV Safety and Efficacy of VI-0521 in Obese Adolescents | $4.2M | 0 | 385 |
| IIT - Anti Obesity Pharmacotherapy vs Patients Using a Wearable Activity Tracker | $535,331 | 0 | 11 |
| IIT - Pancreaze Enzyme Replenishment Therapy | $262,040 | 0 | 6 |
| Long-term Study in US Cystic Fibrosis | $76,406 | 0 | 270 |
| Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms | $40,248 | 0 | 275 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Unknown Provider | — | — | $3.0M | $0 |
| Jorge Plutzky, Md, MD | Cardiovascular Disease | Boston, MA | $263,659 | $0 |
| Dr. Anthony Auriemma, M.d., J.d, M.D., J.D | Family Medicine | Westmont, IL | $68,542 | $0 |
| Dr. Scott Kahan, Md, MD | Public Health & General Preventive Medicine | Chevy Chase, MD | $55,471 | $0 |
| Andres Acosta, M.d., Ph.d, M.D., PH.D | Internal Medicine | Rochester, MN | $33,144 | $0 |
| Dr. Sherry Sakowitz, M.d, M.D | Pediatrics | Brooklyn, NY | $26,796 | $0 |
| Unknown Provider | — | — | $25,319 | $0 |
| Dr. Farhad Zangeneh, Md, MD | Endocrinology, Diabetes & Metabolism | Sterling, VA | $17,924 | $0 |
| Dr. Marina Kurian, Md, MD | Surgery | New York, NY | $17,899 | $0 |
| Dr. Wasim Deeb, M.d, M.D | Endocrinology, Diabetes & Metabolism | Jacksonville, FL | $12,233 | $0 |
| Mr. Luther St. James, M.d, M.D | Family Medicine | Daytona Beach, FL | $10,933 | $0 |
| Mrs. Karlijn Burridge, Pa, PA | Medical | Westmont, IL | $10,735 | $0 |
| Dr. Philip Sager, Md, MD | Cardiovascular Disease | San Francisco, CA | $9,420 | $0 |
| Helena Rodbard, M.d, M.D | Endocrinology, Diabetes & Metabolism | Rockville, MD | $6,960 | $0 |
| Dr. David Irizarry, Md, MD | Endocrinology, Diabetes & Metabolism | Knoxville, TN | $6,342 | $0 |
| Roham Zamanian, Md, MD | Pulmonary Disease | Stanford, CA | $6,184 | $0 |
| Dr. Mitchell Sorsby, M.d, M.D | Endocrinology, Diabetes & Metabolism | Plano, TX | $5,573 | $0 |
| Dr. Lawrence Recht, Md, MD | Neurology | Palo Alto, CA | $5,300 | $0 |
| Dr. Suzanne Cuda, Md, MD | Adolescent Medicine | San Antonio, TX | $5,278 | $0 |
| Dr. Oscar Chien, M.d, M.D | Geriatric Medicine | San Gabriel, CA | $4,914 | $0 |
| Barry Horowitz, M.d, M.D | Endocrinology, Diabetes & Metabolism | West Palm Beach, FL | $3,846 | $0 |
| Jeffrey King, M.d, M.D | Internal Medicine | Denver, CO | $3,710 | $0 |
| Steven Rubin, Md, MD | Gastroenterology | Merrick, NY | $3,702 | $0 |
| Mark Jabro, M.d, M.D | Internal Medicine | San Diego, CA | $3,409 | $0 |
| Folahan Ayoola, Md, MD | Student in an Organized Health Care Education/Training Program | Denton, TX | $3,363 | $0 |
About VIVUS, Inc.
VIVUS, Inc. has made $13.6M in payments to 8,220 healthcare providers, recorded across 24,079 transactions in the CMS Open Payments database. In 2024, the company paid $245,506. The top product by payment volume is QSYMIA ($13.0M).
Payments were distributed across 128 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($281,620 to 52 doctors).
Payment categories include: Food & Beverage ($418,589), Consulting ($487,593), Research ($9.5M), Travel & Lodging ($43,998), Royalties ($3.0M).
VIVUS, Inc. is associated with 4 products in the CMS Open Payments database, including QSYMIA, PANCREAZE, and Qsymia.